COMPASS Pathways launches proposed public offering
London, UK, April 27, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a…
London, UK, April 27, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a…
Earnings Call Scheduled for 8:30 am ET on April 30, 2021 SAN JOSE, Calif., April…
— Fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple…
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative…
PITTSBURGH, April 27, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
– Updated preclinical data will be presented on CRISPR/Cas9-mediated targeted gene insertion to treat alpha-1…
Company to host webcast including leading DM1 expert, Dr. Charles Thornton, following presentations on May…
LONDON, April 27, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company”…
– Abstracts on 4D-150 for wet AMD/DME and 4D-310 for Fabry disease accepted for oral presentations…
BOSTON, April 27, 2021 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine…
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 27, 2021 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
– engEx™ Platform and in vitro and in vivo findings support utility across multiple therapeutic…
Presentations include initial results from preclinical studies of expanded pipeline programs in immune-mediated and metabolic…
WALTHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Affinia Therapeutics, an innovative gene therapy company…
MENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:…
Orphazyme A/SInvestor news No. 05/2021Company Registration No. 32266355 Copenhagen, Denmark and Chicago, IL, USA, April 27, 2021…
BUFFALO, N.Y., April 27, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
SEATTLE, April 27, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
IRVINE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late…